This evening we watched Stryker drop -2.1% to a price of $341.35 per share. The Large-Cap Medical Instruments & Supplies company is now trading -9.94% below its average target price of $379.01. Analysts have set target prices ranging from $345.0 to $406.0 per share for Stryker, and have given the stock an average rating of buy.
Stryker's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.1%. The stock's short ratio is 2.57. The company's insiders own 5.38% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 78.6%. In conclusion, we believe there is positive market sentiment regarding Stryker.
Institutions Invested in Stryker
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-03-31 | Vanguard Group Inc | 8% | 31,459,393 | $10,738,663,992 |
| 2024-03-31 | Blackrock Inc. | 7% | 26,244,709 | $8,958,631,577 |
| 2024-03-31 | Greenleaf Trust | 5% | 18,596,387 | $6,347,876,815 |
| 2024-03-31 | State Street Corporation | 4% | 14,352,621 | $4,899,267,265 |
| 2024-03-31 | Price (T.Rowe) Associates Inc | 3% | 11,879,897 | $4,055,202,913 |
| 2024-03-31 | Wellington Management Group, LLP | 3% | 10,836,402 | $3,699,005,888 |
| 2024-03-31 | Capital Research Global Investors | 3% | 9,982,717 | $3,407,600,508 |
| 2024-03-31 | JP Morgan Chase & Company | 2% | 8,651,403 | $2,953,156,466 |
| 2024-03-31 | Geode Capital Management, LLC | 2% | 6,581,012 | $2,246,428,486 |
| 2024-03-31 | FMR, LLC | 2% | 6,046,379 | $2,063,931,508 |
